Literature DB >> 29879681

(-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine self-administration in rats.

M Manuszak1, W Harding2, S Gadhiya3, R Ranaldi4.   

Abstract

BACKGROUND: Dopamine receptors are implicated in cocaine reward and seeking. We hypothesize that (-)-stepholidine, a dopamine D1/D2/D3 multi-receptor agent, would be effective in reducing cocaine reward and seeking in an animal model. We investigated the effects of (-)-stepholidine in cue-induced reinstatement of cocaine seeking and cocaine self-administration (reward).
METHODS: Cue-induced reinstatement experiment: Rats were trained to press a lever reinforced by cocaine (1 mg/kg/injection) for 15 consecutive daily sessions, after which the response was extinguished by withholding cocaine and cocaine-paired cues (light and pump activation). This was followed by a cue-induced reinstatement test where subjects were exposed to two cocaine cue presentations and presses on the active lever produced cues. Subjects were treated with one of four (-)-stepholidine doses prior to the reinstatement test. Cocaine self-administration (reward) experiment: Rats were trained to self-administer cocaine under a progressive ratio schedule of reinforcement. After stable breakpoints were established, rats were injected with four doses of (-)-stepholidine prior to testing; each dose was injected prior to a separate test session with no-treatment sessions intervening to re-establish break points.
RESULTS: (-)-Stepholidine significantly reduced cue-induced reinstatement of cocaine seeking in a dose-related manner. Additionally, (-)-stepholidine significantly reduced break points for cocaine reward. (-)-Stepholidine did not significantly affect locomotor activity.
CONCLUSIONS: (-)-Stepholidine reduces cue-induced reinstatement of cocaine seeking and cocaine reward, suggesting that it may be useful in treating relapse in cocaine addiction.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (-)-Stepholidine; Cocaine; Drug addiction; Substance use disorder

Mesh:

Substances:

Year:  2018        PMID: 29879681      PMCID: PMC6062455          DOI: 10.1016/j.drugalcdep.2018.04.030

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

1.  Reversing Cocaine-Induced Plasticity with Zeta Inhibitory Peptide.

Authors:  Andre U Deutschmann; Jeffrey D Lenz; Anna G McGrath; Lisa A Briand
Journal:  J Neurosci       Date:  2019-08-13       Impact factor: 6.167

2.  (-)-Stepholidine blocks expression, but not development, of cocaine conditioned place preference in rats.

Authors:  A Bennett; E Barrera; H Namballa; W Harding; R Ranaldi
Journal:  Neurosci Lett       Date:  2020-06-09       Impact factor: 3.046

3.  Low-dose polypharmacology targeting dopamine D1 and D3 receptors reduces cue-induced relapse to heroin seeking in rats.

Authors:  Scott T Ewing; Chris Dorcely; Rivka Maidi; Gulsah Paker; Eva Schelbaum; Robert Ranaldi
Journal:  Addict Biol       Date:  2021-01-25       Impact factor: 4.093

Review 4.  Deep Learning in Drug Discovery and Medicine; Scratching the Surface.

Authors:  Dibyendu Dana; Satishkumar V Gadhiya; Luce G St Surin; David Li; Farha Naaz; Quaisar Ali; Latha Paka; Michael A Yamin; Mahesh Narayan; Itzhak D Goldberg; Prakash Narayan
Journal:  Molecules       Date:  2018-09-18       Impact factor: 4.411

5.  Inclusion of enclosed hydration effects in the binding free energy estimation of dopamine D3 receptor complexes.

Authors:  Rajat Kumar Pal; Satishkumar Gadhiya; Steven Ramsey; Pierpaolo Cordone; Lauren Wickstrom; Wayne W Harding; Tom Kurtzman; Emilio Gallicchio
Journal:  PLoS One       Date:  2019-09-30       Impact factor: 3.240

Review 6.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.